zolpidem for antecollis associated with parkinsonism

zolpidem for antecollis associated with parkinsonism - zolpidem for antecollis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007144

Enrollment

Registered

2012-03-01

Start date

2012-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinsonian syndromes

Interventions

administration of zolpidem

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with antecollis and parkinsonism

Exclusion criteria

Exclusion criteria: Myasthenia gravis Patient with drug allergy for zolpidem

Design outcomes

Primary

Measure	Time frame
improvement of antecollis	—

Countries

Japan

Contacts

Public ContactNaoto Naoto

Tohoku University Dept. of Neurology

sugeno@med.tohoku.ac.jp022-717-7189

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026